NCT04716140

Brief Summary

The aim of this study is to investigate the point or nonsense of treating cartilage lesions at the level of the first metatarsophalane joint. To date, no clear guidelines have been found in the literature with regard to the treatment of cartilage lesions at the MTP I joint during corrective surgery for hallux valgus, nor has it been investigated whether this can have an effect on the clinical outcome.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Sep 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Sep 2020Dec 2026

Study Start

First participant enrolled

September 15, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 9, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 20, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

March 12, 2025

Status Verified

March 1, 2025

Enrollment Period

5.3 years

First QC Date

November 9, 2020

Last Update Submit

March 10, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in AOFAS

    American Orthopaedic Foot and Ankle Society (AOFAS) score - combines a clinician-reported and a patient-reported part for measuring the outcome of treatment in patients who sustained a complex hindfoot injury based on pain, function and alignment: 0 (bad outcome) to 100 (very good outcome)

    10 days, 5 weeks, 4 months, 1 year

  • Change in SF36

    Short Form 36 (SF-36) Health Survey - consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

    10 days, 5 weeks, 4 months, 1 year

  • Change in VAS pain

    Visual Analogue Scale pain score - 0 (no pain) to 10 (worse pain)

    10 days, 5 weeks, 4 months, 1 year

Secondary Outcomes (1)

  • Change in VAS Patient satisfaction

    10 days, 5 weeks, 4 months, 1 year

Study Arms (3)

MTP1 joint with no cartillage laesion or grade I

NO INTERVENTION

Patients in whom no treatment of the cartilage lesions is performed: these patients have no cartilage lesion or a grade I cartilage lesion at the MTP I joint that has been found peroperatively. The degree of the cartilage lesions will be determined on the basis of the ICRS scale and an MS Hololens.

MTP1 joint with cartillage laesion > grade I - non treatment

NO INTERVENTION

Patients in whom a cartilage lesion\> grade 1 is found during surgery randomised in the no treatment group

MTP1 joint with cartillage laesion > grade I - treatment

EXPERIMENTAL

Patients in whom a cartilage lesion\> grade 1 is found during surgery randomised in the treatment group. They will be treated through debridement of the lesion and microfracture.

Procedure: Debridement of the MTP1 cartillage lesion and microfracture

Interventions

Patients with a MTP1 cartillage lesion \> grade I (based on based on the ICRS scale and an MS HoloLens measurement) randomised in the treatment group will be treated with debridement and microfracture

MTP1 joint with cartillage laesion > grade I - treatment

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • hallux valgus

You may not qualify if:

  • younger than 30 years, older than 60 years
  • extra pathologies other than hallux valgus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AZ Maria Middelares

Ghent, 9000, Belgium

RECRUITING

MeSH Terms

Conditions

Hallux Valgus

Condition Hierarchy (Ancestors)

Foot DeformitiesMusculoskeletal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

November 9, 2020

First Posted

January 20, 2021

Study Start

September 15, 2020

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

March 12, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations